biolabs-marketing
As a global company, we have more than 200 talented and well-trained scientists located in different continents working closely with partners from the entire world to develop and produce medicines of tomorrow. Specifically, we are the established leading expert in TCR and CAR T&NK cell immune therapy development, as we offer the one-stop custom services that cover the entire new drug development pipeline.
Altering the specificity of T cell receptor (TCR) is one of the popular strategies to genetically modify T cells to enhance the tumor-killing activity of T cells.
As a leading technology provider, Creative Biolabs has established CellRapeutics™ Chimeric Antigen Receptor (CAR) Technology platform. Learn more about CAR T therapy.
Altering the specificity of T cell receptor (TCR) is one of the popular strategies to genetically modify T cells to enhance the tumor-killing activity of T cells.
As a super provider of diverse antibodies, Creative Biolabs offers customers several approaches for scFv generation such as one-stop solution for developing CAR from Hybridom.
Taking advantage of the CellRapeutics™ platform, Creative Biolabs provides customized, standardized, reliable and high-quality CAR-T preclinical in vivo assay services for clients across the world. Learn more about T Car.
As the leading biotech provider for CAR-T related therapeutic research, Creative Biolabs invested a lot of manpower and material resources to innovate and develop new immunotherapy technologies. Lean more about Safety CAR.
Taking advantage of the CellRapeutics™ platform, Creative Biolabs provides customized, standardized, reliable and high-quality CAR-T preclinical in vivo assay services for clients across the world.
As the leading biotech provider for CAR-T related therapeutic research, Creative Biolabs invested a lot of manpower and material resources to innovate and develop new immunotherapy technologies. Learn more about Armoured CAR.
As a leading technology provider, Creative Biolabs has established CellRapeutics™ Chimeric Antigen Receptor (CAR) Technology platform. Learn more about car t.
CD19 is a B cell surface protein expressed throughout B cell development.
Creative Biolabs is a leading life science service provider that has extensive experience in early, preclinical and clinical stage development of CAR-T cell therapy. Learn more about animal models.
Creative Biolabs offers customers several approaches for scFv generation such as one-stop solution for developing CAR from Hybridoma Cells.
As a leading technology provider, Creative Biolabs has established CellRapeutics™ Chimeric Antigen Receptor (CAR) Technology platform. Learn more about chimeric antigen receptor t-cell.
Immunotherapy has become a revolution in the area of cancer treatment. Compared to the traditional methods, such as invasive surgeries, radiation and chemotherapy, immunotherapy is more specific and less toxic to patients. Learn more about car t development.
Aiming at genetically modifying T cells with designed CAR, our scientists flexibly adopt versatile methodologies to transfect CAR construction into T cells, such as packing and transfection with virus based transfection methods. Learn more about car t plasmid.
Creative Biolabs is a leading life science service provider that has extensive experience in early, preclinical and clinical stage development of CAR-T cell therapy. Learn more about animal models.
Creative Biolabs provides SmarterTM technology of 4th generation CAR construction services for both academic researchers and customers from pharmaceutical industry.Learn more about Safety CAR.
Creative Biolabs provides GLP-compliant in vivo test services for anti-CD19 CAR-T cell therapy in acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and many non-Hodgkin lymphoma (NHL). Learn more about cd19 cell
Creative Biolabs provides SmarterTM safety CAR construction service for customers across the world. Learn more about CAR T safety.
As a leading provider of Chimeric antigen receptors (CARs) products, Creative Biolabs provides unparalleled CellRapeutics? third generation CARs design to satisfy various customers' needs. Learn more about third generation services.
Creative Biolabs provides CellRapeutics™ cytokine release test. Learn more about Cytokine Release Test.
Creative Biolabs now offers one-stop CAR-T therapy development service which has become a promising approach to antitumor therapy. Learn more about T Cell Activation assay.
Based on the outstanding expertise and rich experience, Creative Biolabs has specially developed a systematic approach of phagocytosis assays.Learn more about T Cell Phagocytosis.
Creative Biolabs now presents one-stop CAR-T therapy development service which has become a revolution in the area of cancer therapy. Learn more about T Cell Isolation.
Creative Biolabs now presents one-stop CAR-T therapy development service which has become a more promising approach in the area of cancer therapy.Learn more about Macrophage Polarization.
